Last reviewed · How we verify
Phase IV Study of Nasal Salmon Calcitonin in the Treatment of Symptoms and Signs of Fibromyalgia (CALFI)
The purpose of this study is to determine whether nasal administration of salmon calcitonin is effective and safe in the treatment of symptoms and signs of primary fibromyalgia.
Details
| Lead sponsor | Unidad de Investigacion en Enfermedades Cronico-Degenerativas |
|---|---|
| Phase | Phase 4 |
| Status | WITHDRAWN |
| Start date | 2008-10 |
| Completion | 2009-02 |
Conditions
- Fibromyalgia
Interventions
- salmon calcitonin
- intranasal saline solution plus glycerol
Primary outcomes
- Functional status as assessed by the Fibromyalgia Impact Questionnaire (FIQ), a self-report inventory developed to measure health status in patients with fibromyalgia — Day 0, Day 14, Day 28 and Day 56
Countries
Mexico